Arnim Quante

Summary

Affiliation: Humboldt University
Country: Germany

Publications

  1. ncbi [Psychopharmacologic treatment of personality disorders]
    A Quante
    Charite, Campus Benjamin Franklin, Klinik und Hochschulambulanz für Psychiatrie und Psychotherapie Direktorin Prof Isabella Heuser, Berlin
    Fortschr Neurol Psychiatr 76:139-48. 2008
  2. ncbi Effects of 3 different stimulus intensities of ultrabrief stimuli in right unilateral electroconvulsive therapy in major depression: a randomized, double-blind pilot study
    Arnim Quante
    Department of Psychiatry and Psychotherapy Charité University Medicine Berlin, Campus Benjamin Franklin, Eschenallee 3, 14050 Berlin, Germany
    J Psychiatr Res 45:174-8. 2011
  3. ncbi Aripiprazole as adjunct to a mood stabilizer and citalopram in bipolar depression: a randomized placebo-controlled pilot study
    Arnim Quante
    Department of Psychiatry and Psychotherapy, Charite University Medicine Berlin, Campus Benjamin Franklin, Berlin, Germany
    Hum Psychopharmacol 25:126-32. 2010
  4. ncbi [Psychopharmacological combination therapy in bipolar disorder]
    A Quante
    Klinik und Hochschulambulanz für Psychiatrie und Psychotherapie, Charite Campus Benjamin Franklin, Eschenallee 3, Berlin
    Fortschr Neurol Psychiatr 77:252-62. 2009
  5. ncbi Abnormal cingulate and prefrontal cortical neurochemistry in major depression after electroconvulsive therapy
    Angela Merkl
    Department of Psychiatry Charité Universitätsmedizin, Campus Benjamin Franklin, Berlin, Germany
    Biol Psychiatry 69:772-9. 2011
  6. ncbi Stimulus pulse-frequency-dependent efficacy and cognitive adverse effects of ultrabrief-pulse electroconvulsive therapy in patients with major depression
    Stefan Roepke
    Department of Psychiatry, Campus Benjamin Franklin, Charite Universitatsmedizin Berlin, Germany
    J ECT 27:109-13. 2011
  7. ncbi Inflammatory biomarkers in 70 depressed inpatients with and without the metabolic syndrome
    Sara Zeugmann
    Department of Psychiatry, Charite University Medicine, 14050, Germany
    J Clin Psychiatry 71:1007-16. 2010
  8. ncbi Adjunctive lithium treatment in the prevention of suicidal behaviour in depressive disorders: a randomised, placebo-controlled, 1-year trial
    E Lauterbach
    Department of Psychiatry and Psychotherapy, University of Schleswig Holstein, Campus Luebeck, Luebeck, Germany
    Acta Psychiatr Scand 118:469-79. 2008
  9. ncbi Pathways linking early life stress, metabolic syndrome, and the inflammatory marker fibrinogen in depressed inpatients
    Sara Zeugmann
    Department of Psychiatry and Psychotherapy, Charite, Campus Benjamin Franklin, University Medicine Berlin, Germany
    Psychiatr Danub 24:57-65. 2012
  10. ncbi Psychopharmacological treatment status in outpatients with bipolar disorder: a clinical survey in Germany
    Arnim Quante
    Department of Psychiatry and Psychotherapy, Charite University Medicine Berlin, Campus Benjamin Franklin, Berlin, Germany
    Psychiatry Investig 7:155-62. 2010

Collaborators

Detail Information

Publications11

  1. ncbi [Psychopharmacologic treatment of personality disorders]
    A Quante
    Charite, Campus Benjamin Franklin, Klinik und Hochschulambulanz für Psychiatrie und Psychotherapie Direktorin Prof Isabella Heuser, Berlin
    Fortschr Neurol Psychiatr 76:139-48. 2008
    ..This article gives an overview over the today's most common psychopharmacological treatment possibilities in patients with a personality disorder...
  2. ncbi Effects of 3 different stimulus intensities of ultrabrief stimuli in right unilateral electroconvulsive therapy in major depression: a randomized, double-blind pilot study
    Arnim Quante
    Department of Psychiatry and Psychotherapy Charité University Medicine Berlin, Campus Benjamin Franklin, Eschenallee 3, 14050 Berlin, Germany
    J Psychiatr Res 45:174-8. 2011
    ..In this prospective, randomized, double-blind trial, we examined the efficacy and cognitive side effects of RULECT with three different (high dose) stimulus intensities (4×, 7× and 10× above the seizure threshold (ST))...
  3. ncbi Aripiprazole as adjunct to a mood stabilizer and citalopram in bipolar depression: a randomized placebo-controlled pilot study
    Arnim Quante
    Department of Psychiatry and Psychotherapy, Charite University Medicine Berlin, Campus Benjamin Franklin, Berlin, Germany
    Hum Psychopharmacol 25:126-32. 2010
    ..However, no placebo-controlled studies of adjunctive aripiprazole for the treatment of bipolar depression have been performed yet...
  4. ncbi [Psychopharmacological combination therapy in bipolar disorder]
    A Quante
    Klinik und Hochschulambulanz für Psychiatrie und Psychotherapie, Charite Campus Benjamin Franklin, Eschenallee 3, Berlin
    Fortschr Neurol Psychiatr 77:252-62. 2009
    ..In this review article, studies and results with the focus on combination therapy will be summarised to recommend the "state-of-the-art"-treatment for bipolar disorder...
  5. ncbi Abnormal cingulate and prefrontal cortical neurochemistry in major depression after electroconvulsive therapy
    Angela Merkl
    Department of Psychiatry Charité Universitätsmedizin, Campus Benjamin Franklin, Berlin, Germany
    Biol Psychiatry 69:772-9. 2011
    ....
  6. ncbi Stimulus pulse-frequency-dependent efficacy and cognitive adverse effects of ultrabrief-pulse electroconvulsive therapy in patients with major depression
    Stefan Roepke
    Department of Psychiatry, Campus Benjamin Franklin, Charite Universitatsmedizin Berlin, Germany
    J ECT 27:109-13. 2011
    ..However, effective stimulus dose can often be achieved only with high stimulus frequency, whereas the impact of increased stimulus frequency on antidepressant efficacy and cognitive adverse effects is not known...
  7. ncbi Inflammatory biomarkers in 70 depressed inpatients with and without the metabolic syndrome
    Sara Zeugmann
    Department of Psychiatry, Charite University Medicine, 14050, Germany
    J Clin Psychiatry 71:1007-16. 2010
    ..Chronic subclinical inflammation may be associated with the metabolic syndrome as well as with depression. We examined the impact of the metabolic syndrome on concentrations of inflammatory biomarkers in major depression...
  8. ncbi Adjunctive lithium treatment in the prevention of suicidal behaviour in depressive disorders: a randomised, placebo-controlled, 1-year trial
    E Lauterbach
    Department of Psychiatry and Psychotherapy, University of Schleswig Holstein, Campus Luebeck, Luebeck, Germany
    Acta Psychiatr Scand 118:469-79. 2008
    ..Findings from observational as well as meta-analytic studies strongly suggest that lithium may have suicide-protective properties...
  9. ncbi Pathways linking early life stress, metabolic syndrome, and the inflammatory marker fibrinogen in depressed inpatients
    Sara Zeugmann
    Department of Psychiatry and Psychotherapy, Charite, Campus Benjamin Franklin, University Medicine Berlin, Germany
    Psychiatr Danub 24:57-65. 2012
    ..This study aims at assessing the relationship between components of metabolic syndrome, early life stress and fibrinogen levels, taking the severity of depression into consideration...
  10. ncbi Psychopharmacological treatment status in outpatients with bipolar disorder: a clinical survey in Germany
    Arnim Quante
    Department of Psychiatry and Psychotherapy, Charite University Medicine Berlin, Campus Benjamin Franklin, Berlin, Germany
    Psychiatry Investig 7:155-62. 2010
    ..The objective of this epidemiological study was to evaluate the current treatment status as well as the acceptance of medication and satisfaction with life in outpatients with bipolar disorder in Germany...
  11. ncbi Low novelty seeking and high self directedness scores in alcohol-dependent patients without comorbid psychiatric disorders homozygous for the A10 allele of the dopamine transporter gene
    Ion Anghelescu
    Department of Psychiatry and Psychotherapy, Charite, University Medicine Berlin, Campus Benjamin Franklin, Berlin, Germany
    World J Biol Psychiatry 11:382-9. 2010
    ..Summarizing, the 40-bp VNTR did not help to differentiate between ADP and CO, but might contribute to some personality dimensions in certain ADP subgroups...